{
    "organizations": [],
    "uuid": "fc4539e5859b6813f8acd871fc4bbd0eaea43216",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-biospecifics-technologies-reports/brief-biospecifics-technologies-reports-q1-earnings-per-share-0-54-idUSASC0A0Z7",
    "ord_in_thread": 0,
    "title": "BRIEF-Biospecifics Technologies Reports Q1 Earnings Per Share $0.54",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Biospecifics Technologies Corp:\n* BIOSPECIFICS TECHNOLOGIES CORP. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 REVENUE $7.1 MILLION VERSUS $7.7 MILLION * BIOSPECIFICS - AS OF MARCH 31, 2018, CO HAD CASH AND CASH EQUIVALENTS AND INVESTMENTS OF $64.2 MILLION, COMPARED TO $65.1 MILLION AS OF DEC 31, 2017\n* BIOSPECIFICS - CO’S CASH, CASH EQUIVALENTS WERE SLIGHTLY LOWER DUE TO THE TIMING OF ENDO’S PAYMENT OF ITS QTRLY XIAFLEX ROYALTIES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T20:12:00.000+03:00",
    "crawled": "2018-05-10T17:19:35.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "biospecifics",
        "technology",
        "corp",
        "biospecifics",
        "technology",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "revenue",
        "million",
        "versus",
        "million",
        "biospecifics",
        "march",
        "co",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "compared",
        "million",
        "dec",
        "biospecifics",
        "co",
        "cash",
        "cash",
        "equivalent",
        "slightly",
        "lower",
        "due",
        "timing",
        "endo",
        "payment",
        "qtrly",
        "xiaflex",
        "royalty",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}